Diltiazem is a benzothiazepine calcium channel blocker that slows AV-nodal conduction and dilates coronary and peripheral vasculature, used for angina, hypertension and rate control in supraventricular arrhythmias. Simson Pharma's Diltiazem reference standard and impurities support the high-volume compendial testing this widely prescribed cardiovascular drug demands.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Diltiazem Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.